Overview

Transcutaneous Pulsed Radiofrequency in Migraine

Status:
Active, not recruiting

Trial end date:
2023-06-22

Target enrollment:

Participant gender:

Summary

The aim of the ınvestigator is to compare the efficacy of greater occipital nerve block and transcutaneous pulsed radiofrequency treatment in migraine.

Phase:

N/A

Details

Lead Sponsor:

Diskapi Teaching and Research Hospital

Treatments:

Bupivacaine